Form 4: Relay Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Thomas Catinazzo, CFO of Relay Therapeutics, sold 348 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On March 27, 2024, Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, sold 348 shares of the company's common stock.
- The sale was executed at a price of $7.7 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 992 restricted stock units (RSUs) on March 26, 2024.
- Following the transaction, Catinazzo beneficially owns 341,498 shares of Relay Therapeutics, including 311,643 shares underlying RSUs.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate a positive or negative outlook for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and are generally not indicative of a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/26/2024 | Vesting of 992 shares of restricted stock units (RSUs) |
| 03/27/2024 | Sale of 348 shares of common stock by Thomas Catinazzo |
| 03/29/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.